Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
新規化合物
Document Type and Number:
Japanese Patent JP7261264
Kind Code:
B2
Abstract:
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase LI (UCHL1). The invention further relates to the use of DUB inhibitors in the treatment of cancer and other indications. Compounds of the invention include compounds having the formula (I)or a pharmaceutically acceptable salt thereof, wherein R1 to R8 are as defined herein.

Inventors:
Allison Jones
Mark Ian Kemp
Martin Lee Stockley
Carl Richard Gibson
Gavin Alistair Whitlock
Andrew Madin
Application Number:
JP2021092454A
Publication Date:
April 19, 2023
Filing Date:
June 01, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Mission Therapeutics Limited
International Classes:
C07D401/12; A61K31/4155; A61K31/416; A61K31/4178; A61K31/4184; A61K31/4192; A61K31/422; A61K31/427; A61K31/428; A61K31/433; A61K31/437; A61K31/4375; A61K31/4439; A61K31/444; A61K31/454; A61K31/4545; A61K31/4725; A61K31/496; A61K31/497; A61K31/4985; A61K31/501; A61K31/506; A61K31/519; A61K31/5377; A61K31/551; A61P3/00; A61P11/00; A61P25/00; A61P29/00; A61P31/04; A61P31/12; A61P35/00; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D413/12; C07D413/14; C07D417/12; C07D417/14; C07D471/04; C07D487/04
Domestic Patent References:
JP2003530384A
JP9502979A
JP2013543490A
Attorney, Agent or Firm:
Aoki Atsushi
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Ryotaro Takei